Fragment 176-191
HGH fat loss fragment for targeted body composition
Overview
Fragment 176-191 is the tail end of the human growth hormone molecule (amino acids 176-191). It has been shown to be 12.5 times more potent than regular HGH for fat loss while having no adverse effects on blood sugar or cell proliferation.
Mechanism of Action
Activates lipolysis pathways specific to HGH → stimulates fat breakdown → inhibits new fat formation → does not interact with GH receptors for growth effects.
Benefits
- 12.5x more potent than HGH for fat loss
- No insulin resistance
- No cell proliferation
- Targeted abdominal fat loss
- Supports bone density
Dosing Protocol
Half-Life
~30 minutes
Duration of pharmacological activity after administration.
Side Effects
- Injection site irritation
- Drowsiness (rare)
- Very few reported effects
Stacking Recommendations
Storage & Reconstitution
Lyophilized: -20°C for long-term. Reconstituted: 2–8°C, use within 28 days.
Research Notes
Well-studied HGH fragment with a strong safety profile. Published studies demonstrate effective fat reduction without HGH-related side effects. Widely available in research settings.
Medical Disclaimer
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Peptide therapy should only be initiated under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with your physician before starting any new therapy. Regulatory status varies by jurisdiction.